| Category | Specific Drugs |
| Alkylating agents | Busulfan |
| Carboplatin | |
| Cisplatin | |
| Cyclophosphamide | |
| Ifosfamide | |
| Mechlorethamine | |
| Melphalan | |
| Procarbazine | |
| Thiotepa | |
| Anthracyclines | Daunorubicin |
| Doxorubicin | |
| Epirubicin | |
| Idarubicin | |
| Mitoxantrone | |
| Antimetabolites | 6-Mercaptopurine |
| 6-Thioguanine | |
| Capecitabine | |
| Cytarabine | |
| Fludarabine | |
| Fluorouracil | |
| Gemcitabine | |
| Hydroxyurea | |
| Methotexate | |
| Pemetrexed | |
| Pralatrexate | |
| Antitumor antibiotics | Dactinomycin |
| Bleomycin | |
| Mitomycin | |
| Taxanes | Docetaxel |
| Paclitaxel | |
| Topoisomerase inhibitors | Etoposide |
| Irinotecan | |
| Teniposide | |
| Topotecan | |
| Molecularly targeted agents | Cabozantinib |
| Cetuximab | |
| Erlotinib | |
| Everolimus | |
| Lenvatinib | |
| Palbociclib | |
| Panitumumab | |
| Regorafenib | |
| Sorafenib | |
| Sunitinib | |
| Temsirolimus |
